Literature DB >> 21215493

[Detection of cardiovascular risk factors in patients with psychosis].

Lydia Viñas, Maribel Fernández, Luisa San Emeterio, Luis M Martín-López.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21215493      PMCID： PMC7024919          DOI： 10.1016/j.aprim.2010.04.021

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  6 in total

1.  [Prevalence of metabolic syndrome in patients of an urban primary care centre].

Authors:  M M Coca Díaz; P Hernanz López; M Vega Gómez; C Suárez Fernández
Journal:  Aten Primaria       Date:  2005-05-15       Impact factor: 1.137

2.  Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

Authors:  Joseph P McEvoy; Jonathan M Meyer; Donald C Goff; Henry A Nasrallah; Sonia M Davis; Lisa Sullivan; Herbert Y Meltzer; John Hsiao; T Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2005-08-30       Impact factor: 4.939

3.  Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study.

Authors:  Amber Jennex; David M Gardner
Journal:  Can J Psychiatry       Date:  2008-01       Impact factor: 4.356

4.  A UK audit of screening for the metabolic side effects of antipsychotics in community patients.

Authors:  Thomas R E Barnes; Carol Paton; Mary-Rose Cavanagh; Elizabeth Hancock; David M Taylor
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

Review 5.  Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.

Authors:  A H Barnett; P Mackin; I Chaudhry; A Farooqi; R Gadsby; A Heald; J Hill; H Millar; R Peveler; A Rees; V Singh; D Taylor; J Vora; P B Jones
Journal:  J Psychopharmacol       Date:  2007-06       Impact factor: 4.153

6.  A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study.

Authors:  Celso Arango; Julio Bobes; Pedro Aranda; Rafael Carmena; Margarida Garcia-Garcia; Javier Rejas
Journal:  Schizophr Res       Date:  2008-07-07       Impact factor: 4.939
  6 in total
  1 in total

1.  Recording of cardiovascular risk factors by general practitioners in patients with schizophrenia.

Authors:  Mª Carmen Castillejos; Carlos Martín-Pérez; Antonio García-Ruiz; Fermín Mayoral-Cleries; Berta Moreno-Küstner
Journal:  Ann Gen Psychiatry       Date:  2020-05-19       Impact factor: 3.455
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.